| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ODT | Common Stock | Sale | $1,246,341 | -468,849 | -3% | $2.66* | 15,045,717 | 17 Nov 2021 | By LP | F1, F2 |
| transaction | ODT | Common Stock | Sale | $62,118 | -31,151 | -0.21% | $1.99* | 15,014,566 | 17 Nov 2021 | By LP | F2, F3 |
| transaction | ODT | Common Stock | Sale | $1,008,050 | -500,000 | -3.3% | $2.02* | 14,514,566 | 17 Nov 2021 | By LP | F2, F4 |
| transaction | ODT | Common Stock | Sale | $632,238 | -287,577 | -2% | $2.20* | 14,226,989 | 17 Nov 2021 | By LP | F2, F5 |
| transaction | ODT | Common Stock | Sale | $418,643 | -212,423 | -1.5% | $1.97* | 14,014,566 | 18 Nov 2021 | By LP | F2, F6 |
| transaction | ODT | Common Stock | Sale | $940,600 | -500,000 | -3.6% | $1.88* | 13,514,566 | 18 Nov 2021 | By LP | F2, F7 |
| transaction | ODT | Common Stock | Sale | $722,636 | -381,842 | -2.8% | $1.89* | 13,132,724 | 18 Nov 2021 | By LP | F2, F8 |
| transaction | ODT | Common Stock | Sale | $699,930 | -365,289 | -2.8% | $1.92* | 12,767,435 | 19 Nov 2021 | By LP | F2, F9 |
| Id | Content |
|---|---|
| F1 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $2.01 to $3.01. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 3 through 9 herein. |
| F2 | The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. Michael Hearne is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Financial Officer of TCM. Mr. Tang and Mr. Hearne each have a pecuniary interest in a portion of the shares beneficially held by TCP. |
| F3 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.005. |
| F4 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.95 to $2.07. |
| F5 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.33. |
| F6 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.16. |
| F7 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.99. |
| F8 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.001. |
| F9 | The prices reported in Column 4 are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.985. |